Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Calliditas Therapeutics Major Shareholding Notification 2020

Jan 10, 2020

3020_iss_2020-01-10_efad4613-8a8a-4103-9241-3fa70ff3263d.pdf

Major Shareholding Notification

Open in viewer

Opens in your device viewer

Issuer Calliditas Therapeutics AB

Holder

Stiftelsen Industrifonden

Instrument

Instrument Ordinary shares
Before the transaction
Shares Data not given*
Voting rights Data not given*
Transaction
Reason for major shareholding notification Sell
Date 10/01/2020
Limit for number of shares 15 %
Limit for number of votes 15 %
After the transaction
Quantity
Shares 5,772,995
Directly held voting rights 5,772,995
Indirectly held voting rights 0
Percentage
Directly held shares 14.91436 %
Directly held voting rights 14.91436 %
Indirectly held voting rights 0 %

Resulting distribution of total holdings

Percentage of voting
rights:
Number of underlying
shares:
Shares 14.91436 % 5,772,995
Instruments - FITA Ch. 4, section 2, first
paragraph, line 2
Instruments - FITA Ch. 4, section 2,
first paragraph, line 3
- Physically settled
- Cash settled
Total 14.91436 % 5,772,995
Group
total
holdings
Voting rights
5,772,995
Percentage of voting rights 14.91436
Published
10/01/2020 13:25
*Source of information has chosen not to submit the data

CLOSE PRINT

[email protected] Tfn 08-408 980 37 Fax 08-24 39 25